Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.

Third party commercial assessment shows larger than expected potential total addressable market for IGALMI® in the at-home setting Strong prescriber interest, patient demand, and positive payer ...

But even a charitable nod doesn’t erase the fact that Kennedy’s hyperbole is dangerous advice. Spreading incomplete and ...

Can probiotics help manage bipolar symptoms? Learn what the research says about the gut-brain connection, potential benefits, and safety precautions.

If your bipolar meds aren't effective, talk to your doctor about symptoms, side effects, and potential adjustments. Discover ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

Hypomania involves noticeable mood changes like increased energy, euphoria, and irritability. Hypomanic episodes can be triggered by traumatic, negative, or stressful life events. Effective treatments ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. GLP-1 pills ...

This is an edition of the WSJ Health newsletter, a weekly briefing on what’s new in health, medicine, personal well-being and the business of healthcare. If you’re not subscribed, sign up here.